Table 14, Studies excluded from the health economic review - Evidence review for indications for surgery

Warning: The NCBI web site requires JavaScript to function. more...

Table 14Studies excluded from the health economic review

Reference	Reason for exclusion
Sejean 2005 ⁷⁴	This study was assessed as partially applicable with very serious limitations. The study took a non-UK perspective, and quality of life was not reported directly from patients. Furthermore, the analysis was based on multiple clinical studies (mostly cohort or case-series studies) that have been excluded from this review. In addition, it was considered that there were some assumptions that were likely to be biasing the results, namely that there is no resource use impact from progression, only that some people would then have surgery. Therefore this study was selectively excluded.

Reference

Reason for exclusion

Sejean 2005 ⁷⁴

This study was assessed as partially applicable with very serious limitations. The study took a non-UK perspective, and quality of life was not reported directly from patients. Furthermore, the analysis was based on multiple clinical studies (mostly cohort or case-series studies) that have been excluded from this review. In addition, it was considered that there were some assumptions that were likely to be biasing the results, namely that there is no resource use impact from progression, only that some people would then have surgery. Therefore this study was selectively excluded.

From: Evidence review for indications for surgery

Cover of Evidence review for indications for surgery

Evidence review for indications for surgery: Hyperparathyroidism (primary): diagnosis, assessment and initial management: Evidence review C.

NICE Guideline, No. 132.

National Guideline Centre (UK).

London: National Institute for Health and Care Excellence (NICE); 2019 May.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.